Expanding the evidence for effective therapies in recurrent pericarditis

Abstract

Get full access to this article

View all access options for this article.

References

Berg

Lovrinovic

Baltensperger

, et al. Non-steroidal anti-inflammatory drug use in acute myopericarditis: 12-month clinical follow-up. Open Heart 2019; 6: e000990–e000990.

Bertog

Thambidorai

Parakh

, et al. Constrictive pericarditis: etiology and cause-specific survival after pericardiectomy. J Am Coll Cardiol 2004; 43: 1445–1452.

Sagrista-Sauleda

Angel

Sanchez

, et al. Effusive-constrictive pericarditis. N Engl J Med 2004; 350: 469–475.

Adler

Charron

. The 2015 ESC Guidelines on the diagnosis and management of pericardial diseases. Eur Heart J 2015; 36: 2873–2874.

Imazio

Lazaros

Picardi

, et al. Intravenous human immunoglobulins for refractory recurrent pericarditis: a systematic review of all published cases. J Cardiovasc Med (Hagerstown) 2016; 17: 263–269.

Moretti

Buiatti

Merlo

, et al. Usefulness of high-dose intravenous human immunoglobulins treatment for refractory recurrent pericarditis. Am J Cardiol 2013; 112: 1493–1498.

Vianello

Cinetto

Cavraro

, et al. Azathioprine in isolated recurrent pericarditis: a single centre experience. Int J Cardiol 2011; 147: 477–478.

Brucato

Imazio

Gattorno

, et al. Effect of Anakinra on recurrent pericarditis among patients with colchicine resistance and corticosteroid dependence: the AIRTRIP Randomized Clinical Trial. JAMA 2016; 316: 1906–1912.

Imazio

Andreis

Maria De Ferrari

, et al. Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: the IRAP (International Registry of Anakinra for Pericarditis) study. Eur J Prev Cardiol. 2020; 27: 956–964.

10.

Müller ML, Butler J and Heidecker B. Emerging therapies in transthyretin amyloidosis – a new wave of hope after years of stagnancy? European Journal of Heart Failure. In press.